Geode Capital Management’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q4
Sell
-470,631
Closed -$45.6M 4263
2019
Q3
$45.6M Buy
470,631
+24,262
+5% +$2.35M 0.01% 939
2019
Q2
$45.7M Buy
446,369
+48,960
+12% +$5.01M 0.01% 921
2019
Q1
$45.3M Buy
397,409
+27,409
+7% +$3.12M 0.01% 891
2018
Q4
$14.5M Buy
370,000
+33,414
+10% +$1.31M ﹤0.01% 1507
2018
Q3
$18.4M Buy
336,586
+12,444
+4% +$679K 0.01% 1473
2018
Q2
$26.8M Buy
324,142
+30,076
+10% +$2.49M 0.01% 1142
2018
Q1
$19.6M Buy
294,066
+17,747
+6% +$1.18M 0.01% 1280
2017
Q4
$14.2M Buy
276,319
+4,304
+2% +$221K ﹤0.01% 1500
2017
Q3
$24.3M Buy
272,015
+72,974
+37% +$6.51M 0.01% 1097
2017
Q2
$11.9M Buy
199,041
+21,887
+12% +$1.31M ﹤0.01% 1544
2017
Q1
$9.45M Buy
177,154
+8,284
+5% +$442K ﹤0.01% 1654
2016
Q4
$8.43M Buy
168,870
+5,883
+4% +$294K ﹤0.01% 1699
2016
Q3
$9.79M Buy
162,987
+12,413
+8% +$745K ﹤0.01% 1512
2016
Q2
$7.7M Buy
150,574
+50,009
+50% +$2.56M ﹤0.01% 1628
2016
Q1
$2.97K Buy
100,565
+8,289
+9% +$245 ﹤0.01% 2193
2015
Q4
$4.18M Buy
92,276
+13,868
+18% +$628K ﹤0.01% 1991
2015
Q3
$3.27M Buy
78,408
+20,023
+34% +$835K ﹤0.01% 2121
2015
Q2
$3.52M Buy
+58,385
New +$3.52M ﹤0.01% 2141